Obesity Treatment Stocks Soar on Growth Expectations... How to Maximize the Opportunity

The obesity treatment theme showed a strong upward trend in the domestic stock market. Despite a sideways market, a series of positive developments-such as agreements with global pharmaceutical companies and confirmation of international patents-reinvigorated investor sentiment. The sector surged more than 3% in a single day, ranking among the top gainers following shipbuilding stocks.

Expectations for overseas market expansion also fueled investor optimism. News of next-generation technologies, including the development of long-acting treatments and the expansion of global patents for key strains, drove buying momentum.

The outlook remains optimistic. The global market is expected to grow nearly fivefold by 2030, and with a variety of pipelines and upcoming academic events, there is ample potential for further gains.

[Industry No.1 HighStockLoan Direct Link: https://www.hisl.co.kr/5113]

Meanwhile, interest in stock loans continues to rise. Investors eager not to miss rare investment opportunities are turning to stock loans, which allow them to leverage more funds for stock purchases.

Another advantage of stock loans is that, even if investors face forced liquidation due to a sharp drop in stock prices while using unsettled or margin accounts, they can easily switch to a stock loan without providing additional collateral or selling holdings, and then wait for a market rebound.

◆ HighStockLoan: Industry's lowest annual interest rate in the 4% range for additional investment funds and even refinancing of unsettled or margin accounts!

HighStockLoan has launched a securities-linked credit product with the industry’s lowest annual interest rate in the 4% range, allowing anyone to experience stock loans without burden. It can be used for both stock purchases and refinancing unsettled or margin accounts at securities firms, and is available up to four times the investor’s own capital, regardless of credit rating.

Additionally, for investors who previously had difficulty using stock loans due to DSR (Debt Service Ratio) limits, there are now products available that can be used regardless of DSR. Investors using alternative exchanges (NXT) can also take advantage of these offerings.

Investors interested in HighStockLoan’s diverse, customized products can contact the customer service center (☎1566-5113) for convenient, 24/7 consultations with professional advisors, regardless of loan approval.

○ Launched product with industry’s lowest annual interest rate in the 4% range

○ Offering products regardless of DSR

○ No.1 market share for 21 consecutive years, Korea First Brand Award for 16 consecutive years

○ Real-time repayment of unsettled or margin accounts at securities firms

○ Trading available on alternative exchange (NXT)

○ Reliable consultation quality guarantee system

* HighStockLoan Consultation Center: 1566-5113

Direct Link: https://www.hisl.co.kr/5113

SK Hynix, Samsung Electronics, Hanwha Ocean, Doosan Enerbility, Samsung Heavy Industries

※ The above content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.

This content was produced with the assistance of AI translation services.